Blueprint Medicines Corporation (BPMC): Price and Financial Metrics


Blueprint Medicines Corporation (BPMC)

Today's Latest Price: $96.91 USD

5.99 (-5.82%)

Updated Jan 26 6:55pm

Add BPMC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 484 in Biotech

See all "A" rated Strong Buy stocks

BPMC Stock Summary

  • Of note is the ratio of Blueprint Medicines Corp's sales and general administrative expense to its total operating expenses; only 16.52% of US stocks have a lower such ratio.
  • In terms of twelve month growth in earnings before interest and taxes, Blueprint Medicines Corp is reporting a growth rate of -187.63%; that's higher than merely 10.34% of US stocks.
  • As for revenue growth, note that BPMC's revenue has grown 4,965.96% over the past 12 months; that beats the revenue growth of 99.77% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Blueprint Medicines Corp are CLSD, TBIO, LIFE, DRNA, and RCUS.
  • BPMC's SEC filings can be seen here. And to visit Blueprint Medicines Corp's official web site, go to www.blueprintmedicines.com.

BPMC Stock Price Chart Interactive Chart >

Price chart for BPMC

BPMC Price/Volume Stats

Current price $96.91 52-week high $125.61
Prev. close $102.90 52-week low $43.29
Day low $96.54 Volume 300,100
Day high $104.00 Avg. volume 448,894
50-day MA $107.73 Dividend yield N/A
200-day MA $85.74 Market Cap 5.40B

Blueprint Medicines Corporation (BPMC) Company Bio


Blueprint Medicines Corporation makes kinase drugs to treat patients with genomically defined diseases. The company was founded in 2008 and is based in Cambridge, Massachusetts.


BPMC Latest News Stream


Event/Time News Detail
Loading, please wait...

BPMC Latest Social Stream


Loading social stream, please wait...

View Full BPMC Social Stream

Latest BPMC News From Around the Web

Below are the latest news stories about Blueprint Medicines Corp that investors may wish to consider to help them evaluate BPMC as an investment opportunity.

AzurRx (AZRX) Starts Dosing in Pancreatic Insufficiency Study

AzurRX (AZRX) is developing its pipeline candidate, MS1819, as monotherapy as well in combination with standard of care for treating exocrine pancreatic insufficiency in patients with cystic fibrosis.

Yahoo | January 22, 2021

Blueprint Medicines (BPMC) Upgraded to Strong Buy: Here's What You Should Know

Blueprint Medicines (BPMC) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | January 20, 2021

3 Biotech Stocks Poised to Outperform Amid Coronavirus Pandemic

3 Biotech Stocks Poised to Outperform Amid Coronavirus Pandemic

Yahoo | January 13, 2021

Blueprint Medicines Announces R&D Leadership Transitions

CAMBRIDGE, Mass., Jan. 11, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced leadership transitions for the company's research and development organization. Effective as of January 11, 2021, Becker Hewes, M.D., currently Senior Vice President, Clinical…

PR Newswire | January 11, 2021

Infrastructure and Energy Alternatives, Carrols Restaurant, Moderna, Blueprint Medicines and Halozyme Therapeutics highlighted as Zacks Bull and Bear of the Day

Infrastructure and Energy Alternatives, Carrols Restaurant, Moderna, Blueprint Medicines and Halozyme Therapeutics highlighted as Zacks Bull and Bear of the Day

Yahoo | January 11, 2021

Read More 'BPMC' Stories Here

BPMC Price Returns

1-mo -20.86%
3-mo -9.29%
6-mo 32.43%
1-year 48.84%
3-year 16.74%
5-year 516.48%
YTD -13.59%
2020 40.00%
2019 48.60%
2018 -28.51%
2017 168.84%
2016 6.49%

Continue Researching BPMC

Want to see what other sources are saying about Blueprint Medicines Corp's financials and stock price? Try the links below:

Blueprint Medicines Corp (BPMC) Stock Price | Nasdaq
Blueprint Medicines Corp (BPMC) Stock Quote, History and News - Yahoo Finance
Blueprint Medicines Corp (BPMC) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8158 seconds.